Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC’s Congestion Pricing Pulls In $48.
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...
Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Investopedia on MSN7d
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in ChinaConcerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 – a sharp decline from the $2.8bn recorded in the ...
The JN.1-adapted COVID-19 vaccines for children aged six months to 11 years have been used up, so starting from yesterday, ...
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback